Disease Focus: Thymic Disorder, 22q11 Deletion/DiGeorge

---

Regenerative Thymic Tissues as Curative Cell Therapy for Patients with 22q11 Deletion Syndrome

Research Objective We propose a platform to generate transplantable thymus organoids derived from human pluripotent stem cells designed to treat severe immunodeficiencies in children affected by 22q11 DS Impact Our product could impact 22q11DS and many other pathologies characterized by absence, degeneration or injury of the thymus and resulting in severe immunodeficiencies. Major Proposed Activities […]